Streetbeat News

Stock Prices

CISO

CISO Global Inc has announced that Nasdaq has decided to delist the company's securities. According to an SEC filing, trading of CISO Global's common stock will be suspended at the opening of business on January 8, 2024.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 9:29 pm

UONE

Urban One has received a notice from Nasdaq confirming that the company is now in compliance with the periodic filing rule, indicating that it has addressed previous issues with filing its financial reports on time.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 9:29 pm

GCT

GigaCloud Technology Inc (NASDAQ:GCT) shares surged nearly 14% on Thursday, reaching 52-week highs, driven by strong third-quarter earnings and a raised price target from Roth MKM analyst Matt Koranda from $16 to $18. The stock's rally added to gains of over 50% in the past month, with trading volume reaching 3.36 million, significantly higher than the average of 975,194. The stock closed up 10.2% at $20.47.

Portfolio Pulse from Ryan Gustafson

January 04, 2024 | 9:28 pm

CTO

PINE

CTO Realty Growth, Inc. (NYSE:CTO) reported its 2023 activities, including the acquisition of four retail properties and one land parcel for $80 million, and a first mortgage structured investment of $15 million. The company also purchased shares of Alpine Income Property Trust, Inc. (PINE) and sold nine non-core income properties and other assets. CTO signed 92 leases, showing rent growth, and repurchased common and Series A Preferred shares. As of year-end, CTO had 22,643,034 common shares outstanding.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 9:23 pm

TPET

Trio Petroleum Corp (NYSE:TPET) announced the restart of the McCool Ranch Oil Field, with production from six previously producing wells. The San Ardo Water Disposal Well WD-1 has been refurbished, and on-site facilities are being tested and repaired. The field, idle since 2015 due to low oil prices, is expected to provide significant cash flow for the company with current oil prices and approved permits. The field has the potential for additional drilling, and the restart is seen as a positive step towards increasing shareholder value.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 9:17 pm

SGLY

Singularity Future Technology (SGLY) received a notice from Nasdaq regarding a potential delisting due to non-compliance with listing rules, as per an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 9:10 pm

ALLO

Allogene Therapeutics, Inc. (NASDAQ:ALLO) announced its 2024 Platform Vision, focusing on allogeneic CAR T products for cancer and autoimmune diseases. The ALPHA3 trial aims to establish cemacabtagene ansegedleucel (cema-cel) as a frontline treatment for Large B-Cell Lymphoma (LBCL) patients with minimal residual disease (MRD). The ALPHA2 trial in Chronic Lymphocytic Leukemia (CLL) and the ALLO-329 program for Autoimmune Disease (AID) are also highlighted. The TRAVERSE trial with ALLO-316 in Renal Cell Carcinoma (RCC) is advancing with a new treatment algorithm. Allogene's manufacturing facility, Cell Forge 1, is expected to meet future demand for AlloCAR T products. The company plans to reduce cash burn and extend its financial runway into 2026. A conference call is scheduled to discuss the vision, and Dr. Chang will present at the J.P. Morgan Healthcare Conference.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 9:09 pm

SCPH

ScPharmaceuticals reported preliminary Q4 revenue for FUROSCIX between $5.9M and $6.1M, surpassing the estimated $5.32M.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 9:08 pm

TACT

TransAct Technologies Incorporated has received approval from an unnamed Quick Service Restaurant (QSR) to sell its BOHA! Terminal 2 in the US domestic market. This approval could lead to increased sales and market penetration for TransAct's product.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 9:07 pm

FC

Franklin Covey (NYSE:FC) reported Q1 earnings per share of $0.36, a 12.5% increase from $0.32 YoY. Sales reached $68.40M, surpassing the $65.88M estimate but marking a 1.40% decrease from $69.37M in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 9:04 pm